Bilim V - Search Results

1

Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.

Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y. Hara N, et al. Among authors: bilim v. Clin Cancer Res. 2002 Jun;8(6):1794-9. Clin Cancer Res. 2002. PMID: 12060619 Clinical Trial.

2

Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.

Tomita Y, Bilim V, Kawasaki T, Takahashi K, Okan I, Magnusson KP, Wiman KG. Tomita Y, et al. Among authors: bilim v. Int J Cancer. 1996 May 3;66(3):322-5. doi: 10.1002/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8621251

3

Tetrapeptide DEVD-aldehyde or YVAD-chloromethylketone inhibits Fas/Apo-1(CD95)-mediated apoptosis in renal-cell-cancer cells.

Tomita Y, Kawasaki T, Bilim V, Takeda M, Takahashi K. Tomita Y, et al. Among authors: bilim v. Int J Cancer. 1996 Sep 27;68(1):132-5. doi: 10.1002/(SICI)1097-0215(19960927)68:1<132::AID-IJC23>3.0.CO;2-C. Int J Cancer. 1996. PMID: 8895553

4

Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations.

Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K, Kumanishi T. Kawasaki T, et al. Among authors: bilim v. Int J Cancer. 1996 Nov 15;68(4):501-5. doi: 10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7. Int J Cancer. 1996. PMID: 8945622

5

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.

Bilim VN, Tomita Y, Kawasaki T, Takeda M, Takahashi K. Bilim VN, et al. Cancer Lett. 1998 Jun 5;128(1):87-92. doi: 10.1016/s0304-3835(98)00055-x. Cancer Lett. 1998. PMID: 9652797

6

Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).

Bilim VN, Kawasaki T, Takahashi K, Tomita Y. Bilim VN, et al. Anticancer Res. 1998 May-Jun;18(3A):1655-9. Anticancer Res. 1998. PMID: 9673385

7

Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.

Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y. Bilim V, et al. Clin Cancer Res. 2000 Feb;6(2):460-6. Clin Cancer Res. 2000. PMID: 10690524

8

Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and adriamycin on transitional cell cancer cells.

Bilim V, Kasahara T, Noboru H, Takahashi K, Tomita Y. Bilim V, et al. Cancer Lett. 2000 Jul 31;155(2):191-8. doi: 10.1016/s0304-3835(00)00428-6. Cancer Lett. 2000. PMID: 10822135

9

Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.

Ougolkov A, Mai M, Takahashi Y, Omote K, Bilim V, Shimizu A, Minamoto T. Ougolkov A, et al. Among authors: bilim v. J Exp Clin Cancer Res. 2000 Sep;19(3):349-55. J Exp Clin Cancer Res. 2000. PMID: 11144528

10

Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.

Bilim V, Kawasaki T, Takahashi K, Tomita Y. Bilim V, et al. J Exp Clin Cancer Res. 2000 Dec;19(4):483-8. J Exp Clin Cancer Res. 2000. PMID: 11277327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results